Health Care & Hospital Law
Jan. 26, 2011
9th Circuit Reinforces Drug Rules
A unanimous 9th U.S. Circuit Court of Appeals panel ruled Monday that federal law does not preempt state law failure-to-warn claims against a generic drug manufacturer, reversing a ruling by James Ware, the new chief judge of the Northern District.
Daily Journal Staff Writer
SAN FRANCISCO - A unanimous 9th U.S. Circuit Court of Appeals panel ruled Monday federal law does not preempt state law failure-to-warn claims against a generic drug manufacturer, reversing a ruling by James Ware, the new chief judge of the Northern District.
The decision reinforces the idea generic drug manufacturers have the same legal responsibilities as brand-name drug makers to provide adequate ...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In